Cardiovascular Risk and Health Among People With HIV Eligible for Primary Prevention: Insights From the REPRIEVE Trial

Clicks: 73
ID: 266783
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #867 of 1,084 articles by views in clinical infectious diseases

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 1,084 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
AbstractBackground. In addition to traditional cardiovascular (CV) risk factors, antiretroviral therapy, lifestyle, and HIV-related factors may contribute to fu
Reference Key
sclinicalcardiovascular Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Douglas, Pamela S;Umbleja, Triin;Bloomfield, Gerald S;Fichtenbaum, Carl J;Zanni, Markella V;Overton, Edgar T;Fitch, Kathleen V;Kileel, Emma M;Aberg, Judith A;Currier, Judith;Sponseller, Craig A;Melbourne, Kathleen;Avihingsanon, Anchalee;Bustorff, Flavio;Estrada, Vicente;Ruxrungtham, Kiat;Saumoy, Maria;Navar, Ann Marie;Hoffmann, Udo;Ribaudo, Heather J;Grinspoon, Steven;REPRIEVE Investigators;
Journal clinical infectious diseases
Year Year not found
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.